Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial

Primo N Lara, Catherine Tangen, Elisabeth I Heath, Shuchi Gulati, Mark N Stein, Maxwell Meng, Ajjai Shivaram Alva, Sumanta K Pal, Igor Puzanov, Joseph I Clark, Toni K. Choueiri, Neeraj Agarwal, Robert Uzzo, Naomi B Haas, Timothy W Synold, Melissa Plets, Ulka N Vaishampayan, Brian M Shuch, Seth Lerner, Ian M ThompsonChristopher W Ryan

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial'. Together they form a unique fingerprint.

Medicine and Dentistry